Literature DB >> 16377829

Myasthenic crisis.

David Lacomis1.   

Abstract

Myasthenic crisis is a serious occurrence, affecting up to 27% of patients with myasthenia gravis. In the approach to the patient with myasthenic crisis, (1) the diagnosis of myasthenia gravis is confirmed; (2) respiratory failure is evaluated and treated in the intensive care unit, while potential precipitating factors are identified and managed; (3) immunomodulatory treatment is initiated; and (4) complications are avoided or managed promptly. The mortality rate should be 5% or less, with the elderly being most vulnerable.

Entities:  

Mesh:

Year:  2005        PMID: 16377829     DOI: 10.1385/NCC:3:3:189

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  35 in total

1.  Letter: beta-Blockers and myasthenia gravis.

Authors:  Y Herishanu; P Rosenberg
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

2.  Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis.

Authors:  Atsushi Watanabe; Toshiaki Watanabe; Takuro Obama; Tohru Mawatari; Hisayoshi Ohsawa; Yasunori Ichimiya; Noriyuki Takahashi; Katsuyuki Kusajima; Tomio Abe
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

3.  Myasthenia gravis after interferon-alpha treatment.

Authors:  E Lensch; J Faust; W A Nix; E Wandel
Journal:  Muscle Nerve       Date:  1996-07       Impact factor: 3.217

Review 4.  How to handle myasthenic crisis. Essential steps in patient care.

Authors:  R S Bedlack; D B Sanders
Journal:  Postgrad Med       Date:  2000-04       Impact factor: 3.840

5.  The neuromuscular effects of quinidine.

Authors:  R D Miller; W L Way; B G Katzung
Journal:  Proc Soc Exp Biol Med       Date:  1968-10

6.  BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation.

Authors:  Alejandro Rabinstein; Eelco F M Wijdicks
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

7.  Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.

Authors:  R C Bucknall; J Dixon A St; E N Glick; J Woodland; D W Zutshi
Journal:  Br Med J       Date:  1975-03-15

8.  Cardiac disease in myasthenia gravis: a literature review.

Authors:  Maya Guglin; Joseph V Campellone; Kathleen Heintz; Joseph E Parrillo
Journal:  J Clin Neuromuscul Dis       Date:  2003-06

9.  Aspects of the natural history of myasthenia gravis: crisis and death.

Authors:  M S Cohen; D Younger
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

10.  The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

Authors:  P Rieder; M Louis; P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

View more
  16 in total

1.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

Review 2.  Treatment of myasthenia gravis: focus on pyridostigmine.

Authors:  Lorenzo Maggi; Renato Mantegazza
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

3.  The effect of secular trends and specialist neurocritical care on mortality for patients with intracerebral haemorrhage, myasthenia gravis and Guillain-Barré syndrome admitted to critical care : an analysis of the Intensive Care National Audit & Research Centre (ICNARC) national United Kingdom database.

Authors:  Maxwell S Damian; Yoav Ben-Shlomo; Robin Howard; Tony Bellotti; David Harrison; Kathryn Griggs; Kathryn Rowan
Journal:  Intensive Care Med       Date:  2013-05-24       Impact factor: 17.440

4.  [Myasthenia gravis].

Authors:  J Schodrowski; M Seipelt; I Adibi-Sedeh; C Eienbröker; B Tackenberg
Journal:  Internist (Berl)       Date:  2016-04       Impact factor: 0.743

5.  Clinical Outcomes of Thymectomy in Myasthenia Gravis Patients with a History of Crisis.

Authors:  Zhenguo Liu; Yingrong Lai; Shiyuan Yao; Huiyu Feng; Jianyong Zou; Weibin Liu; Yiyan Lei; Hua Zhu; Chao Cheng
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

6.  Current and emerging therapies for the treatment of myasthenia gravis.

Authors:  Renato Mantegazza; Silvia Bonanno; Giorgia Camera; Carlo Antozzi
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-22       Impact factor: 2.570

7.  Myasthenic Crisis in an Elderly Patient with Positive Antibodies against Acetylcholine and Anti-MuSK, Successfully Treated with Noninvasive Mechanical Ventilation.

Authors:  José A Fernández; Antonio Fernández-Valiñas; Daniel Hernández; Joel Orozco; Antonio Lugo
Journal:  Case Rep Crit Care       Date:  2015-12-10

8.  Myasthenia gravis with acute respiratory failure in the emergency department.

Authors:  Hasan Huseyin Kozak; Ali Ulvi Uca; Turgut Teke; Mustafa Altas; Emine Karatas
Journal:  Turk J Emerg Med       Date:  2016-05-08

9.  Myasthenic Crisis Complicated with Myxedema, Positive for Both Anti-acetylcholine Receptor and Anti-muscle-specific Tyrosine Kinase Antibodies.

Authors:  Kazuhiro Horiuchi; Azusa Nagai; Masahiro Wakita; Shotaro Ito; Kei Takamura; Hideki Houzen
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

10.  Predictors of extubation outcomes following myasthenic crisis.

Authors:  Zhenguo Liu; Shiyuan Yao; Qian Zhou; Zhensheng Deng; Jianyong Zou; Huiyu Feng; Hua Zhu; Chao Cheng
Journal:  J Int Med Res       Date:  2016-11-18       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.